Go to deals
Financial Services

CCAF 18 de Septiembre has completed the placement of commercial paper

Caja de Compensación de Asignación Familiar 18 de Septiembre (CCAF 18 de Septiembre) has raised funds.

CCAF 18 de Septiembre is a non-profit, private corporation with over 50 years of experience in administering social security benefits granted by the state of Chile. Among these benefits are household allowances, unemployment benefits and work disability allowances, among others. It also offers additional services such as social credits and legal counseling.

Oaklins’ team in Chile acted as sole financial advisor of CCAF 18 de Septiembre in the placement of commercial paper in the local market for a total amount of US$6.1 million.

Talk to the deal team

Sebastián Cereceda

Partner
Santiago, Chile
Oaklins LarrainVial

Sofía Castro

Associate
Santiago, Chile
Oaklins LarrainVial

Valentina Rodríguez

Analyst
Santiago, Chile
Oaklins LarrainVial

Related deals

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Financial Services | Healthcare

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Learn more
Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida
Private Equity | Financial Services

Microfinanciera Fundeser has been sold to Grupo Financiero Atlántida

Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.

Learn more
doValue has finalized a rights issue
Financial Services

doValue has finalized a rights issue

doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.

Learn more